{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:36:17Z","timestamp":1791434177125,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFA0507100"],"award-info":[{"award-number":["2018YFA0507100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170692"],"award-info":[{"award-number":["82170692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000634"],"award-info":[{"award-number":["32000634"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Foundation of Jiangsu Province","award":["2020ZB263"],"award-info":[{"award-number":["2020ZB263"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Shiga toxin (Stx)-induced hemolytic uremic syndrome (HUS) poses a life-threatening complication for which a definitive treatment remains elusive. To exert its cytotoxic effect on renal cells, Stx must be delivered from the infected intestines to the kidney. However, the mechanism underlying Stx delivery remains unclear. Here we pinpoint monocytes as the primary carriers responsible for transporting Stx2 to the renal region. Through single-cell sequencing analysis of Stx2-B-bound peripheral white blood cells sorted by flow cytometry, we observe that nearly all monocytes exhibit strong Stx2-B binding, whereas less than 10% of neutrophils are associated with Stx2-B, albeit with a lower affinity. Further examination of the single-cell dataset and cell binding assays suggest that monocytes likely bind to Stx2-B through the Toll-like receptor 4. Remarkably, Stx-laden monocytes demonstrate their ability to transport Stx2 to human renal glomerular endothelial cells (HRGEC), subsequently inducing apoptosis in HRGEC. In a mouse model of Stx1\/2-positive EDL933 infection-induced HUS, the presence of Stx2-positive monocytes in peripheral blood and infiltrated kidney tissues was observed. Finally, depleting monocytes through the usage of a CD14 neutralizing antibody or blocking monocyte chemotaxis via inhibition of CCL2 notably mitigates kidney injury and dysfunction caused by lipopolysaccharide (LPS)\/Stx2 treatment. Our findings unveil the pivotal role of monocytes in Stx delivery during STEC infection and offer a promising therapeutic approach for Stx-induced HUS.<\/jats:p>","DOI":"10.1186\/s11658-025-00689-8","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:14:22Z","timestamp":1737980062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome"],"prefix":"10.1186","volume":"30","author":[{"given":"Xinlei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"5","key":"689_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41390-021-01622-3","volume":"91","author":"DS Sanchez","year":"2022","unstructured":"Sanchez DS, Fischer Sigel LK, Balestracci A, Ibarra C, Amaral MM, Silberstein C. Eliglustat prevents Shiga toxin 2 cytotoxic effects in human renal tubular epithelial cells. Pediatr Res. 2022;91(5):1121\u20139.","journal-title":"Pediatr Res"},{"key":"689_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.EHEC-0024-2013","author":"AR Melton-Celsa","year":"2014","unstructured":"Melton-Celsa AR. Shiga toxin (Stx) classification, structure, and function. Microbiol Spectr. 2014. https:\/\/doi.org\/10.1128\/microbiolspec.EHEC-0024-2013.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"689_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1128\/IAI.71.3.1497-1504.2003","volume":"71","author":"WE Smith","year":"2003","unstructured":"Smith WE, Kane AV, Campbell ST, Acheson DW, Cochran BH, Thorpe CM. Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells. Infect Immun. 2003;71(3):1497\u2013504.","journal-title":"Infect Immun"},{"issue":"3","key":"689_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1096\/fj.01-0521com","volume":"16","author":"M Brigotti","year":"2002","unstructured":"Brigotti M, Alfieri R, Sestili P, Bonelli M, Petronini PG, Guidarelli A, Barbieri L, Stirpe F, Sperti S. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J. 2002;16(3):365\u201372.","journal-title":"FASEB J"},{"issue":"1","key":"689_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1055\/s-0039-3400301","volume":"120","author":"M Brigotti","year":"2020","unstructured":"Brigotti M, He X, Carnicelli D, Arfilli V, Porcellini E, Galassi E, Tazzari PL, Ricci F, Patfield SA, Testa S, et al. Particulate Shiga toxin 2 in blood is associated to the development of hemolytic uremic syndrome in children. Thromb Haemost. 2020;120(1):107\u201320.","journal-title":"Thromb Haemost"},{"issue":"12","key":"689_CR6","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1111\/apa.13211","volume":"104","author":"X He","year":"2015","unstructured":"He X, Quinones B, Loo MT, Loos S, Scavia G, Brigotti M, Levtchenko E, Monnens L. Serum Shiga toxin 2 values in patients during acute phase of diarrhoea-associated haemolytic uraemic syndrome. Acta Paediatr. 2015;104(12):e564-568.","journal-title":"Acta Paediatr"},{"issue":"12","key":"689_CR7","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/toxins15120690","volume":"15","author":"E Varrone","year":"2023","unstructured":"Varrone E, Carnicelli D, He X, Grasse M, Stampfer K, Huber S, Kellnerova S, Tazzari PL, Ricci F, Paterini P, et al. Detection of cleaved Stx2a in the blood of STEC-infected patients. Toxins. 2023;15(12):690.","journal-title":"Toxins"},{"issue":"10","key":"689_CR8","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/archpediatrics.2012.471","volume":"166","author":"RK Mody","year":"2012","unstructured":"Mody RK, Luna-Gierke RE, Jones TF, Comstock N, Hurd S, Scheftel J, Lathrop S, Smith G, Palmer A, Strockbine N, et al. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying Shiga toxin-producing Escherichia coli. Arch Pediatr Adolesc Med. 2012;166(10):902\u20139.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"689_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/toxins13110775","volume":"13","author":"Y Lee","year":"2021","unstructured":"Lee Y, Kim MH, Alves DR, Kim S, Lee LP, Sung JH, Park S. Gut-kidney axis on chip for studying effects of antibiotics on risk of hemolytic uremic syndrome by Shiga toxin-producing Escherichia coli. Toxins. 2021;13(11):775.","journal-title":"Toxins"},{"issue":"11","key":"689_CR10","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1182\/blood.V95.11.3396","volume":"95","author":"DM Te Loo","year":"2000","unstructured":"Te Loo DM, Monnens LA, van Der Velden TJ, Vermeer MA, Preyers F, Demacker PN, van Den Heuvel LP, van Hinsbergh VW. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood. 2000;95(11):3396\u2013402.","journal-title":"Blood"},{"issue":"4","key":"689_CR11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1681\/ASN.V124800","volume":"12","author":"D Te Loo","year":"2001","unstructured":"Te Loo D, Hinsbergh V, Heuvel L, Monnens LAH. Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol. 2001;12(4):800\u20136.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"689_CR12","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.4049\/jimmunol.1300122","volume":"191","author":"M Brigotti","year":"2013","unstructured":"Brigotti M, Carnicelli D, Arfilli V, Tamassia N, Borsetti F, Fabbri E, Tazzari PL, Ricci F, Pagliaro P, Spisni E, et al. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils. J Immunol. 2013;191(9):4748\u201358.","journal-title":"J Immunol"},{"issue":"2","key":"689_CR13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/IAI.01594-06","volume":"75","author":"MJ Flagler","year":"2007","unstructured":"Flagler MJ, Strasser JE, Chalk CL, Weiss AA. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis. Infect Immun. 2007;75(2):760\u20135.","journal-title":"Infect Immun"},{"issue":"3","key":"689_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/ndt\/gfl688","volume":"22","author":"JM Geelen","year":"2007","unstructured":"Geelen JM, van der Velden TJ, Te Loo DM, Boerman OC, van den Heuvel LP, Monnens LA. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrol Dial Transplant. 2007;22(3):749\u201355.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"689_CR15","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1128\/IAI.72.11.6680-6684.2004","volume":"72","author":"KR Winter","year":"2004","unstructured":"Winter KR, Stoffregen WC, Dean-Nystrom EA. Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes. Infect Immun. 2004;72(11):6680\u20134.","journal-title":"Infect Immun"},{"issue":"1","key":"689_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1574-695X.2010.00749.x","volume":"61","author":"ML Torgersen","year":"2011","unstructured":"Torgersen ML, Engedal N, Pedersen AM, Husebye H, Espevik T, Sandvig K. Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells. FEMS Immunol Med Microbiol. 2011;61(1):63\u201375.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"689_CR17","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1038\/s41598-018-22327-4","volume":"8","author":"S Niu","year":"2018","unstructured":"Niu S, Paluszynski J, Bian Z, Shi L, Kidder K, Liu Y. LPS-primed CD11b(+) leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice. Sci Rep. 2018;8(1):3994.","journal-title":"Sci Rep"},{"issue":"4","key":"689_CR18","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ajpath.2012.12.026","volume":"182","author":"DJ Stearns-Kurosawa","year":"2013","unstructured":"Stearns-Kurosawa DJ, Oh SY, Cherla RP, Lee MS, Tesh VL, Papin J, Henderson J, Kurosawa S. Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli Shiga toxins in non-human primate models of hemolytic uremic syndrome. Am J Pathol. 2013;182(4):1227\u201338.","journal-title":"Am J Pathol"},{"issue":"2","key":"689_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004619","volume":"11","author":"AL St\u00e5hl","year":"2015","unstructured":"St\u00e5hl AL, Arvidsson I, Johansson KE, Chromek M, Rebetz J, Loos S, Kristoffersson AC, B\u00e9k\u00e1ssy ZD, M\u00f6rgelin M, Karpman D. A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog. 2015;11(2): e1004619.","journal-title":"PLoS Pathog"},{"issue":"7535","key":"689_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature14064","volume":"517","author":"HF Renard","year":"2015","unstructured":"Renard HF, Simunovic M, Lemiere J, Boucrot E, Garcia-Castillo MD, Arumugam S, Chambon V, Lamaze C, Wunder C, Kenworthy AK, et al. Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis. Nature. 2015;517(7535):493\u20136.","journal-title":"Nature"},{"key":"689_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70692","volume":"10","author":"JE Olivieri","year":"2021","unstructured":"Olivieri JE, Dehghannasiri R, Wang PL, Jang S, de Morree A, Tan SY, Ming J, Ruohao Wu A, Tabula Sapiens C, Quake SR, et al. RNA splicing programs define tissue compartments and cell types at single-cell resolution. Elife. 2021;10: e70692.","journal-title":"Elife"},{"issue":"1","key":"689_CR22","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1038\/s41467-022-35297-z","volume":"13","author":"CM McEvoy","year":"2022","unstructured":"McEvoy CM, Murphy JM, Zhang L, Clotet-Freixas S, Mathews JA, An J, Karimzadeh M, Pouyabahar D, Su S, Zaslaver O, et al. Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity. Nat Commun. 2022;13(1):7634.","journal-title":"Nat Commun"},{"issue":"5","key":"689_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1152\/physiolgenomics.00124.2021","volume":"54","author":"Y Kume","year":"2022","unstructured":"Kume Y, Go H, Maeda R, Suyama K, Mori T, Kawasaki Y, Hashimoto K, Hosoya M. Gene expression profile and injury sites in mice treated with Shiga toxin 2 and lipopolysaccharide as a Shiga toxin-associated hemolytic uremic syndrome model. Physiol Genom. 2022;54(5):153\u201365.","journal-title":"Physiol Genom"},{"issue":"11","key":"689_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1074\/mcp.M400106-MCP200","volume":"3","author":"VL Bonilha","year":"2004","unstructured":"Bonilha VL, Bhattacharya SK, West KA, Sun J, Crabb JW, Rayborn ME, Hollyfield JG. Proteomic characterization of isolated retinal pigment epithelium microvilli. Mol Cell Proteom. 2004;3(11):1119\u201327.","journal-title":"Mol Cell Proteom"},{"key":"689_CR25","first-page":"258185","volume":"2011","author":"KL Mohawk","year":"2011","unstructured":"Mohawk KL, O\u2019Brien AD. Mouse models of Escherichia coli O157:H7 infection and Shiga toxin injection. J Biomed Biotechnol. 2011;2011:258185.","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"689_CR26","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/biomedicines10051193","volume":"10","author":"X Sun","year":"2022","unstructured":"Sun X, Shi F, Wang W, Wu Y, Qu S, Li J, Liang H, Zen K. Myeloid-specific pyruvate-kinase-type-M2-deficient mice are resistant to acute lung injury. Biomedicines. 2022;10(5):1193.","journal-title":"Biomedicines"},{"issue":"7170","key":"689_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nature05996","volume":"450","author":"W R\u00f6mer","year":"2007","unstructured":"R\u00f6mer W, Berland L, Chambon V, Gaus K, Windschiegl B, Tenza D, Aly MR, Fraisier V, Florent JC, Perrais D, et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature. 2007;450(7170):670\u20135.","journal-title":"Nature"},{"key":"689_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fcimb.2020.00123","volume":"10","author":"C Lingwood","year":"2020","unstructured":"Lingwood C. Verotoxin receptor-based pathology and therapies. Front Cell Infect Microbiol. 2020;10:123.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1\u20132","key":"689_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jneuroim.2010.03.001","volume":"222","author":"C Tironi-Farinati","year":"2010","unstructured":"Tironi-Farinati C, Loidl CF, Boccoli J, Parma Y, Fernandez-Miyakawa ME, Goldstein J. Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities. J Neuroimmunol. 2010;222(1\u20132):48\u201361.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"689_CR30","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.2353\/ajpath.2008.071218","volume":"173","author":"C Calderon Toledo","year":"2008","unstructured":"Calderon Toledo C, Rogers TJ, Svensson M, Tati R, Fischer H, Svanborg C, Karpman D. Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Am J Pathol. 2008;173(5):1428\u201339.","journal-title":"Am J Pathol"},{"key":"689_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micpath.2016.05.010","volume":"97","author":"KK Olavesen","year":"2016","unstructured":"Olavesen KK, Lindstedt BA, Lobersli I, Brandal LT. Expression of Shiga toxin 2 (Stx2) in highly virulent Stx-producing Escherichia coli (STEC) carrying different anti-terminator (q) genes. Microb Pathog. 2016;97:1\u20138.","journal-title":"Microb Pathog"},{"issue":"7","key":"689_CR32","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.ijmm.2018.06.013","volume":"308","author":"M Brigotti","year":"2018","unstructured":"Brigotti M, Carnicelli D, Arfilli V, Porcellini E, Galassi E, Valerii MC, Spisni E. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome. Int J Med Microbiol. 2018;308(7):940\u20136.","journal-title":"Int J Med Microbiol"},{"issue":"20","key":"689_CR33","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","volume":"117","author":"AL St\u00e5hl","year":"2011","unstructured":"St\u00e5hl AL, Sartz L, Karpman D. Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood. 2011;117(20):5503\u201313.","journal-title":"Blood"},{"issue":"6","key":"689_CR34","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.kint.2022.09.004","volume":"102","author":"A Chen","year":"2022","unstructured":"Chen A, Lee K, He JC. Treating crescentic glomerulonephritis by targeting macrophages. Kidney Int. 2022;102(6):1212\u20134.","journal-title":"Kidney Int"},{"key":"689_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13872","author":"W Jiang","year":"2023","unstructured":"Jiang W, Xu T, Song Z, Wang X, Yuan S, Li Q, Wei Y, Wang C, Yang G, Cao J, et al. CCL2 is a key regulator and therapeutic target for periodontitis. J Clin Periodontol. 2023. https:\/\/doi.org\/10.1111\/jcpe.13872.","journal-title":"J Clin Periodontol"},{"issue":"6","key":"689_CR36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1203\/00006450-199806000-00008","volume":"43","author":"PA Van Setten","year":"1998","unstructured":"Van Setten PA, Van Hinsbergh VW, Van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA. Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res. 1998;43(6):759\u201367.","journal-title":"Pediatr Res"},{"issue":"1","key":"689_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1182\/blood.V88.1.174.174","volume":"88","author":"PA Van Setten","year":"1996","unstructured":"Van Setten PA, Monnens LA, Verstraten RG, van den Heuvel LP, van Hinsbergh VW. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood. 1996;88(1):174\u201383.","journal-title":"Blood"},{"issue":"8","key":"689_CR38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-007-0512-4","volume":"22","author":"JM Geelen","year":"2007","unstructured":"Geelen JM, van der Velden TJ, van den Heuvel LP, Monnens LA. Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr Nephrol. 2007;22(8):1181\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"4 Pt 1","key":"689_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1203\/01.pdr.0000203100.45658.d5","volume":"59","author":"H Decaluwe","year":"2006","unstructured":"Decaluwe H, Harrison LM, Mariscalco MM, Gendrel D, Bohuon C, Tesh VL, Proulx F. Procalcitonin in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. Pediatr Res. 2006;59(4 Pt 1):579\u201383.","journal-title":"Pediatr Res"},{"issue":"6","key":"689_CR40","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/eji.201747138","volume":"48","author":"JM Pohl","year":"2018","unstructured":"Pohl JM, Volke JK, Thiebes S, Brenzel A, Fuchs K, Beziere N, Ehrlichmann W, Pichler BJ, Squire A, Gueler F, et al. CCR2-dependent Gr1(high) monocytes promote kidney injury in Shiga toxin-induced hemolytic uremic syndrome in mice. Eur J Immunol. 2018;48(6):990\u20131000.","journal-title":"Eur J Immunol"},{"key":"689_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/978-1-0716-1339-9_17","volume":"2291","author":"G Hall","year":"2021","unstructured":"Hall G, Kurosawa S, Stearns-Kurosawa DJ. Infection of immunocompetent conventional mice with Shiga toxin-producing E. coli: the DSS + STEC model. Methods Mol Biol. 2021;2291:353\u201364.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"689_CR42","doi-asserted-by":"publisher","first-page":"2113717","DOI":"10.1080\/19490976.2022.2113717","volume":"14","author":"H Shuwen","year":"2022","unstructured":"Shuwen H, Kefeng D. Intestinal phages interact with bacteria and are involved in human diseases. Gut Microbes. 2022;14(1):2113717.","journal-title":"Gut Microbes"},{"issue":"6","key":"689_CR43","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1159\/000088523","volume":"25","author":"F Clayton","year":"2005","unstructured":"Clayton F, Pysher TJ, Lou R, Kohan DE, Denkers ND, Tesh VL, Taylor FB Jr, Siegler RL. Lipopolysaccharide upregulates renal Shiga toxin receptors in a primate model of hemolytic uremic syndrome. Am J Nephrol. 2005;25(6):536\u201340.","journal-title":"Am J Nephrol"},{"issue":"12","key":"689_CR44","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1681\/ASN.2006050419","volume":"17","author":"TR Keepers","year":"2006","unstructured":"Keepers TR, Psotka MA, Gross LK, Obrig TG. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol. 2006;17(12):3404\u201314.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"689_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00467-003-1395-7","volume":"19","author":"M Ikeda","year":"2004","unstructured":"Ikeda M, Ito S, Honda M. Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol. 2004;19(5):485\u20139.","journal-title":"Pediatr Nephrol"},{"key":"689_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.EHEC-0005-2013","author":"F Obata","year":"2014","unstructured":"Obata F, Obrig T. Role of Shiga\/Vero toxins in pathogenesis. Microbiol Spectr. 2014. https:\/\/doi.org\/10.1128\/microbiolspec.EHEC-0005-2013.","journal-title":"Microbiol Spectr"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00689-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00689-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00689-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:16:24Z","timestamp":1737980184000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00689-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00689-8","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the Declaration of Helsinki (as revised in 2013), and written consent for tissue donation was obtained from each patient. The protocol was approved by the Institutional Review Board of Nanjing Drum Tower Hospital of Nanjing University (approval no. 2020\u2013311-03; approved 10 June 2021). The protocols were approved by the Animal Research Ethics Board of China Pharmaceutical University (Nanjing, China, no. 2020\u201307-002; approved 12 March 2020) following the Guidelines for the Care and Use of Animals. The study involving animals was conducted following the Basel Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript has been approved by all the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}